Trial NCT00622687

View at ClinicalTrials.gov 
Org. Study IDs: ILO-1998
Secondary IDs: Schering GmbH

Last trial update was posted on 2008-02-25

MeSH Interventions

Iloprost

MeSH Conditions

Scleroderma, Diffuse Scleroderma, Systemic Sclerosis

Other Conditions

Systemic Sclerosis

Stopping Reasons

sufficient number to reach the primary endpoint and as planned

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID